Regulation of p53 in response to DNA damage
The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
Activation of p53 can occur in response to a number of cellular stresses, including DNA damage, hypoxia and nucleotide deprivation. Several forms of DNA damage have been shown to activate p53, including those generated by ionising radiation (IR), radio-mimetic drugs, ultraviolet light (UV) and chemicals such as methyl methane sulfonate (MMS). Under normal conditions, p53 levels are maintained at a low state by virtue of the extremely short-half life of the polypeptide. In addition to this, p53 normally exists in an largely inactive state that is relatively inefficient at binding to DNA and activating transcription. Activation of p53 in response to DNA damage is associated with a rapid increase in its levels and with an increased ability of p53 to bind DNA and mediate transcriptional activation. This then leads to the activation of a number of genes whose products trigger cell-cycle arrest, apoptosis, or DNA repair. Recent work has suggested that this regulation is brought about largely through DNA damage triggering a series of phosphorylation, de-phosphorylation and acetylation events on the p53 polypeptide. Here, we discuss the nature of these modifications, the enzymes that bring them about, and how changes in p53 modification lead to p53 activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UV-induced phosphorylation at Serine 15 increased p53 stability and protein level that associated with DNA damage [61].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [61]
In the citing paper
“Under normal conditions, cellular p53 protein levels are very low owing to strict control by its negative regulators MDM2 and MDMX, which promote p53 degradation through ubiquitination.27,28”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [28]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 4,296
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · cited 2×
“Interaction of Mdm2 with this N-terminal region of p53 has been demonstrated to inhibit the ability of p53 to activate transcription (Momand et al., 1992; Oliner et al., 1993).”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“Initial clues suggesting that ATM may be involved in regulation of p53 in response to DNA damage came from observations that cell cycle checkpoint controls and up-regulation of p53 in response to IR are defective in A-T cells (Kastan et al., 1992; Khanna and Lavin, 1993; Canman et al., 1994).”
BackgroundHistone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884 · cited 1×
“Further support for this idea has been provided by the demonstration that certain histone acetyl-transferase (HAT) enzymes correspond to key transcriptional coactivators, such as CBP/p300 and PCAF (for reviews see Grunstein, 1997; Kouzarides, 1999).”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785 · cited 1×
“The gene mutated in ataxia-telangiectasia patients was mapped to human chromosome 11q2223, and the gene, termed ATM, has been cloned (Gatti et al., 1988; Savitsky et al., 1995).”
BackgroundActivation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · cited 2×
“Thus, in addition to potentially playing a role in acetylating histones at p53-dependent promoters, CBP/p300 has been shown to be able to acetylate p53 at lysine-373 and lysine-382, whilst PCAF can acetylate p53 at lysine-320 (Gu and Roeder, 1997; Sakaguchi, 1998; Liu et al., 1999).”
BackgroundKo, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344 · cited 4×
“Elevated levels of p21 then inhibit the cyclin E/cdk2 and cyclin A/cdk2 kinases, thus preventing these kinases from promoting cell cycle progression (for review, see Ko and Prives, 1996; Levine, 1997).”
BackgroundInfluential
Research works printed but not linked: 3
- Lakin ND, Hann BC and Jackson SP. . 1999 Oncogene in press.
- Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E and Anderson CW. . 1992 Mol. Cell. Biol. 12: 5041–5049. · doi:10.1128/mcb.12.11.5041-5049.1992 · Paper page
- Maltzman W and Czyzyk L. . 1984 Mol. Cell. Biol. 4: 1689–1694. · DOI · Paper page
Cited by
Items 501–600 of 1,000
Photoprotection in Human Skin—A Multifaceted SOS Response†
Eller, M. S., Asarch, A., & Gilchrest, B. A. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00264.x · Cited by 30
Mutation at p53 serine 389 does not rescue the embryonic lethality in mdm2 or mdm4 null mice
Iwakuma, T., Parant, J. M., Fasulo, M., Zwart, E., Jacks, T., de Vries, A., & Lozano, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207793 · Cited by 27
“A growing number of studies have indicated the importance of the post-translational modifications of p53 in regulating its activity (Lakin and Jackson, 1999; Appella and Anderson, 2001).”
BackgroundSuzuki, T., & Tsukamoto, I. (2006) · Toxicology Letters · doi:10.1016/j.toxlet.2006.05.004 · Cited by 28
Mukherjee, A., Sikdar, S., Bishayee, K., Boujedaini, N., & Khuda‐Bukhsh, A. R. (2013) · Cell Proliferation · doi:10.1111/cpr.12079 · Cited by 33
“This observation would tempt one to suggest that upregulation of p53 was possibly caused by DNA damage through intercalation of flavonol with DNA, in conformity with the proposition of Lakin and Jackson, 1999 (31) for a similar result.”
ResultBALB/c alleles for Prkdc and Cdkn2a interact to modify tumor susceptibility in Trp53+/- mice.
Blackburn, A. C., Brown, J. S., Naber, S. P., Otis, C. N., Wood, J. T., & Jerry, D. J. (2003) · PubMed · Cited by 34
Prep1 Directly Regulates the Intrinsic Apoptotic Pathway by Controlling Bcl-XL Levels
Micali, N., Ferrai, C., Fernández, L. C., Blasi, F., & Crippa, M. P. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01273-08 · Cited by 27
“Mitochondrial deficiency and the anomalous response to genotoxic stress may depend on increased nuclear levels of p53 and the consequent upregulation of proapoptotic and downregulation of antiapoptotic genes (16, 24).”
BackgroundReprogramming cellular senescence and aging clocks for advanced cancer immunotherapy
Yang, H., Liu, D., Qiu, L., Wang, R., Zhang, C., Yu, D., Zhong, Q., Yuki, N., Song, Z., Zhu, Τ., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02459-8 · Cited by 38
“…NF-κB, MAPK pathway [68] Table 1 Senescence-associated secretory phenotype Multiple stressors (e.g., DNA breaks, oncogenic signals) activate p53 [84], which upregulates p21CIP1 to induce Rb hypophosphorylation and E2F sequestra-tion—this hypophosphorylated Rb then blocks G1/S and G2/M…”
Seth, E., Ahsan, A. U., Kaushal, S., Mehra, S., & Chopra, M. (2021) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2021.104977 · Cited by 26
MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response
Kawano, I., & Adamcová, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1055911 · Cited by 27
“One of the most critical downstream targets of ATM is p53, which is activated into a form with improved DNA binding affinity and rapidly accumulates inside of the cell to induce cell cycle arrest, DNA repair, and apoptosis (Lakin and Jackson, 1999; Cheng and Chen, 2010).”
BackgroundLu, C., Liu, X., Liu, C., Wang, J., Li, C., Liu, Q., Li, Y., Li, S., Sun, S. W., Yan, J., et al. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv153 · Cited by 26
Takeba, Y., Matsumoto, N., Watanabe, M., Nakaya, S., Ohta, Y., Kumai, T., Takagi, M., Koizumi, S., Asakura, T., & Otsubo, T. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1862-6 · Cited by 26
p53: its alteration and gallbladder cancer
Rai, R., Tewari, M., Mohan Kumar, H., Singh, A. K., & Shukla, H. S. (2010) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328341e371 · Cited by 26
“The cascade of events signalling from DNA lesions to stabilization and activation of p53 in the nucleus is still controversial (Lakin and Jackson, 1999; Valenzuela et al., 2002).”
BackgroundShinwari, Z., Manogaran, P. S., Alrokayan, S., Al‐Hussein, K., & Aboussekhra, A. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9502-4 · Cited by 28
“p53 and p21 are key tumor suppressor proteins that are upregulated in response to various cellular stresses, including DNA damage [26–28].”
BackgroundThe Urine Proteome as a Radiation Biodosimeter
Sharma, M., & Moulder, J. E. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-5896-4_5 · Cited by 26
“We speculated that TBI-induced injury may result in excretion of modified proteins in the urine [66, 67].”
BackgroundBasu, T., Panja, S., Ghate, N. B., Chaudhuri, D., & Mandal, N. (2016) · Cytotechnology · doi:10.1007/s10616-016-0051-6 · Cited by 28
“Previously it has been shown that upregulation of p53 took place due to DNA damage and replicative errors, thereby arresting cells at the G2/M check point and activation of target gene, p21 (Agarwal et al. 1998; Lakin and Jackson 1999).”
BackgroundWiesmann, N., Strozynski, J., Beck, C., Zimmermann, N., Mendler, S., Gieringer, R., Schmidtmann, I. M., & Brieger, J. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx006 · Cited by 28
NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity
Haider, N., Dutt, P., van de Kooij, B., Ho, J., Palomero, L., Pujana, M. Á., Yaffe, M. B., & Stambolic, V. (2020) · Oncogene · doi:10.1038/s41388-020-1361-x · Cited by 28
“Central to many of the cellular damage response pathways is the tumor suppressor p53 [2, 47, 48].”
BackgroundOxidation of methionine residue at hydrophobic core destabilizes p53 tetrameric structure
Nomura, T., Kamada, R., Ito, I., Chuman, Y., Shimohigashi, Y., & Sakaguchi, K. (2008) · Biopolymers · doi:10.1002/bip.21084 · Cited by 28
Park, G. B., Park, S. H., Kim, D., Kim, Y. S., Yoon, S. H., & Hur, D. Y. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3502 · Cited by 29
A novel mechanism for pergolide-induced neuroprotection: inhibition of NF-κB nuclear translocation
Uberti, D. L., Carsana, T., Francisconi, S., Ferrari‐Toninelli, G., Canonico, P. L., & Memo, M. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.01.012 · Cited by 26
Mujoo, K., Watanabe, M., Nakamura, J., Khokhar, A. R., & Siddik, Z. H. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0480-4 · Cited by 28
“A major outcome of p53 phosphorylation is to enable the tumor suppressor to transctivate a number of genes that are essential for cell-cycle arrest and apoptosis (Laskin and Jackson 1999; Sionov and Haupt 1999).”
Backgroundp53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistance
Zhang, J., Tan, P., Guo, L., Gong, J., Ma, J., Li, J., Lee, M., Fang, S., Ji, J., Johnson, G. S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0524-5 · Cited by 30
“Since p53 expression can be rapidly upregulated in tumor cells in response to anti-cancer therapy (e.g., doxorubicin-based chemotherapy or radiotherapy) (36), we asked whether therapeutics-triggered p53 upregulation could reduce TET2 protein levels in HCT116 cells.”
SPOP regulates the DNA damage response and lung adenocarcinoma cell response to radiation.
Dong, Y., Zhang, D., Cai, M., Luo, Z., Zhu, Y., Gong, L., Lei, Y., Tan, X., Zhu, Q., & Han, S. (2019) · PubMed · Cited by 28
Das, B., Sahoo, S., & Mallick, B. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120353 · Cited by 25
Inborn Errors of Purine Salvage and Catabolism
Camici, M., Garcia‐Gil, M., Allegrini, S., Pesi, R., Bernardini, G., Micheli, V., & Tozzi, M. G. (2023) · Metabolites · doi:10.3390/metabo13070787 · Cited by 28
Senapati, J., Müftüoğlu, M., Ishizawa, J., Abbas, H. A., Loghavi, S., Borthakur, G. M., Yilmaz, M. E., Issa, G. C., Dara, S., Basyal, M., et al. (2023) · Blood Cancer Journal · doi:10.1038/s41408-023-00871-1 · Cited by 28
“Multiple mechanisms are involved in maintaining the intricate balance of TP53 gene expression and functional p53 protein levels [2, 3].”
BackgroundMehdizadeh, R., Ansari, A. M., Forouzesh, F., Shahriari, F., Shariatpanahi, S. P., Salaritabar, A., & Javidi, M. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-38021-z · Cited by 27
Ueno, M., Katayama, K., Yamauchi, H., Nakayama, H., & Doi, K. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.11.024 · Cited by 25
Bizarro, A., Ferreira, I. C. F. R., Sokóvić, M., van Griensven, L., Sousa, D., Vasconcelos, M. H., & Lima, R. T. (2015) · Molecules · doi:10.3390/molecules200813927 · Cited by 25
“Activation of p53 may result from DNA damage [22,28].”
BackgroundXinarianos, G., Liloglou, T., Prime, W., Sourvinos, G., Karachristos, A., Gosney, J. R., Spandidos, D. A., & Field, J. K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10598 · Cited by 25
Ascochlorin activates p53 in a manner distinct from DNA damaging agents
Jeong, J.-H., Nakajima, H., Magae, J., Furukawa, C., Taki, K., Otsuka, K., Tomita, M., Lee, I., Kim, C., Chang, H., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24259 · Cited by 26
Kúdelová, J., Seifrtová, M., Jandová, L., Tomšík, P., Havelek, R., & Řezáčová, M. (2013) · Journal of Applied Biomedicine · doi:10.2478/v10136-012-0033-8 · Cited by 25
Bash-Babula, J., Toppmeyer, D., Labassi, M., Reidy, J., Orlick, M., Senzon, R., Alli, E., Kearney, T. J., August, D. A., Shih, W., et al. (2002) · PubMed · Cited by 25
p53‐induced inhibition of protein synthesis is independent of apoptosis
Constantinou, C., Bushell, M., Jeffrey, I. W., Tilleray, V. J., West, M., Frost, V. J., Hensold, J. O., & Clemens, M. J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03687.x · Cited by 25
Enhancement of UVB-induced DNA damage repair after a chronic low-dose UVB pre-stimulation
Drigeard Desgarnier, M.-C., & Rochette, P. J. (2018) · DNA Repair · doi:10.1016/j.dnarep.2018.01.008 · Cited by 24
Marco, K. D., Sanese, P., Simone, C., & Grossi, V. (2023) · Cancers · doi:10.3390/cancers15204976 · Cited by 26
“…of non-histone DDR proteins, such as the tumor suppressor p53, which is regulated by several PTMs [100]. p53 is an important player in DDR, as it regulates checkpoint activation, induces cell cycle arrest and apoptosis, and blocks DNA repair [101]. p53 is methylated by the HMT SMYD2 at lysine K370.”
BackgroundAhmed, M. A. M., & Nagelkerke, A. (2021) · Organs-on-a-Chip · doi:10.1016/j.ooc.2021.100012 · Cited by 25
Islam, S., Kamila, S., & Chattopadhyay, A. (2022) · Journal of Environmental Science and Health Part C · doi:10.1080/26896583.2022.2158675 · Cited by 33
“The tumor suppressor p53 activation in response to DNA damages is associated with a rapid augmentation in its levels, which leads to the activation of a number of genes responsible for cell-cycle arrest, apoptosis or DNA repair.(77) Induction in the formation of bulky adducts and subsequent damages in both dA’s as wel…”
BackgroundRoselle, C., Horikawa, I., Chen, L., Kelly, A. R., Gonzales, D. M., Da, T., Wellhausen, N., Rommel, P. C., Baker, D., Suhoski, M. M., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317735121 · Cited by 28
Beggs, K. M., Maiuri, A. R., Fullerton, A. M., Poulsen, K. L., Breier, A. B., Ganey, P. E., & Roth, R. A. (2015) · Toxicology · doi:10.1016/j.tox.2015.03.002 · Cited by 25
“DNA strand breaks can lead to upregulation of the transcription factor and tumor suppressor protein, p53 (Lakin and Jackson, 1999).”
BackgroundBrüsehafer, K., Rees, B. J., Manshian, B. B., Doherty, A., O’Donovan, M. R., Doak, S. H., & Jenkins, G. J. S. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu058 · Cited by 24
“p53 activation was investigated by assessing p53 and phopho-p53 (Ser15) protein expression analysis, as DNA damage induces phosphorylation of p53 at serine residues (Lakin and Jackson, 1999).”
BackgroundEurycomanone Induces Apoptosis through the Up- Regulation of p53 in Human Cervical Carcinoma Cells
Mahfudh, N., Pihie, A. H. L., & Pihie, L. (2008) · Cited by 24
Bhatt, M., Ivan, C., Xie, X., & Siddik, Z. H. (2016) · Oncotarget · doi:10.18632/oncotarget.14228 · Cited by 24
“Thus, p53 in AT cells is not responsive to DNA strand breaks by ionizing radiation due to loss of ATM kinase, but its regulation is restored by DNA adducts induced by ultraviolet radiation or cis-Pt that instead activate the intact, closely-related ATR kinase [42, 43].”
BackgroundPan, L., Lee, Y. M., Lim, T. K., Lin, Q., & Xu, X. (2018) · Small · doi:10.1002/smll.201800190 · Cited by 24
Vaghefi, H., & Neet, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207953 · Cited by 28
“Acetylation of p53 was widely believed to be synonymous with the activation of the tumor suppressor (Bayle and Crabtree, 1997; Lakin and Jackson, 1999; Grossman, 2001; Woods and Vousden, 2001).”
BackgroundHah, Y., Kim, J. G., Cho, H. Y., Park, J. S., Heo, E. P., & Yoon, T. (2017) · Oncology Letters · doi:10.3892/ol.2017.6422 · Cited by 24
“Conversely, in normal cells, cell cycle progression is regulated by cell cycle check points (22).”
Thiamine antagonists trigger p53-dependent apoptosis in differentiated SH-SY5Y cells
Chornyy, S., IuM, P., & Chorna, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-10878-x · Cited by 24
Lyche, J. L., Grześ, I. M., Karlsson, C., Nourizadeh-Lillabadi, R., Aleström, P., & Ropstad, E. (2016) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2016.1171991 · Cited by 26
“Subsequently, oxidative DNA damage may lead to p53 and caspase 2 activation and initiate downstream apoptotic events enhancing further activation of caspases (Lakin and Jackson, 1999).”
BackgroundERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function
Bado, I., Pham, E., Soibam, B., Nikolos, F., Gustafsson, J.-Α., & Thomas, C. G. (2018) · Oncotarget · doi:10.18632/oncotarget.25147 · Cited by 25
“Nuclear accumulation of p53 is essential for its transcriptional activation in response to DNA damage [59].”
The DNA damage response pathway regulates the expression of the immune checkpoint CD47
Ghantous, L., Volman, Y., Hefez, R., Wald, O., Stern, E., Friehmann, T., Chajut, A., Bremer, E., Elhalel, M. D., & Rachmilewitz, J. (2023) · Communications Biology · doi:10.1038/s42003-023-04615-6 · Cited by 27
Ellipticine derivative induces potent cytostatic effect in acute myeloid leukaemia cells
Russell, E. G., O’Sullivan, E. C., Miller, C. M., Stanicka, J., McCarthy, F. O., & Cotter, T. G. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0140-3 · Cited by 24
“p53 expression was examined as this tumour suppressor gene is activated by DNA damage [27].”
BackgroundPhosphorylation and Stabilization of TAp63γ by IκB Kinase-β
MacPartlin, M., Zeng, S. X., & Lu, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801394200 · Cited by 27
Díez-Quijada, L., Hercog, K., Štampar, M., Filipič, M., Cameán, A. M., Jos, A. M., & Žegura, B. (2020) · Toxins · doi:10.3390/toxins12120778 · Cited by 23
“In response to DNA damage, the p53 protein is mostly activated via the phosphorylation by DNA damage responsive kinases and, to a minor part, by the up-regulation of gene expression [67].”
BackgroundKim, E., Kim, J., Kim, H., Lee, B. R., Choi, E., & In, S. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s89593 · Cited by 23
“If the p53 damage response pathway fails to protect against DNA damage, cancer progression will occur.(51) Therefore, p53 is increased upon DNA damage, and combination of the comet assay with detection of molecular markers, such as p53, offers a comprehensive approach for the assessment of DNA damage in vitro.”
BackgroundSamuni, A. M., Kasid, U. N., Chuang, E. Y.-Y., Suy, S., DeGraff, W., Krishna, M. C., Russo, A., & Mitchell, J. B. (2005) · Cancer Research · doi:10.1158/0008-5472.579.65.2 · Cited by 23
Ghorai, A., Sarma, A., Bhattacharyya, N. P., & Ghosh, U. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1107-3 · Cited by 23
Involvement of p53 in 1-$beta;-arabinofuranosylcytosine-induced rat fetal brain lesions
Yamauchi, H., Katayama, K., Ueno, M., Uetsuka, K., Nakayama, H., & Doi, K. (2004) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2004.03.010 · Cited by 25
Liang, X., Guo, Y., Figg, W. D., Fojo, A. T., Mueller, M. D., & Yu, J. (2010) · Chemotherapy Research and Practice · doi:10.1155/2011/715469 · Cited by 23
“The transcription factor p53, a DNA-binding protein containing DNA-binding, oligomerization, and transcriptional activation domains [3–6], plays a key role in the DNA damage response to genotoxic stress by binding directly to the promoters of target genes and altering the rate at which they are transcribed [7, 8].”
BackgroundHrstka, R., Powell, D. J., Kvardová, V., Roubalová, E., Bourougaa, K., Candeias, M. M., Sova, P., Zak, F., Fåhræus, R., & Vojtěšek, B. (2008) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3282f7f500 · Cited by 22
Radiosensitivity of Cancer Cells Is Regulated by Translationally Controlled Tumor Protein
Jung, J., Lee, J. S., Lee, Y., & Lee, K. (2019) · Cancers · doi:10.3390/cancers11030386 · Cited by 23
“Since p53 level is increased in cells with DNA damage [33] and p53 and TCTP work as reciprocal regulators [5], we used TCTP down-regulated A549 cells to observe the changes in p53 and MDM2 levels after radiation.”
MethodMachuldová, A., Holubová, M., Caputo, V. S., Čedíková, M., Jindra, P., Houdová, L., & Pitule, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.651751 · Cited by 22
“Hyperproliferative state could also trigger DNA damage response (63), and so activate p53 (64).”
BackgroundFlint, S. J., Huang, W., Goodhouse, J., & Kyin, S. (2005) · Virology · doi:10.1016/j.virol.2005.04.007 · Cited by 25
Peng, Z., Koh, C. Z. Y., Li, Q., Manikandan, J., MELENDEZ, A., Tang, S., Halliwell, B. B., & CHEUNG, N. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.016 · Cited by 22
A study on the extracts of Cuscuta reflexa Roxb. in treatment of cyclophosphamide induced alopecia
Patel, S., Sharma, V., Chauhan, N. S., & Dixit, V. K. (2014) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-22-7 · Cited by 22
“This apoptosis largely depends on p53, a key mediator of cellular mechanism of stress response [16].”
Yeom, S., Kim, S. S., Jeong, H., & Jang, K. L. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000856 · Cited by 22
Wong, J., Li, P.-X., & Klamut, H. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203020200 · Cited by 31
The Ins and Outs of HOPS/TMUB1 in biology and pathology
Fazia, M. A. D., Castelli, M., Piobbico, D., Pieroni, S., & Servillo, G. (2020) · FEBS Journal · doi:10.1111/febs.15539 · Cited by 21
Tran, A. P., Tralie, C. J., Reyes, J. S., Moosmüller, C., Belkhatir, Z., Kevrekidis, I. G., Levine, A. J., Deasy, J. O., & Tannenbaum, A. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01069-x · Cited by 24
“Decades of research in molecular and cellular biology delineated signal transduction pathways that mediate response to growth factors stimulation [1], DNA damage [2, 3], changes in nutrient abundance [4] and oxygen availability [5], among others.”
BackgroundRoy, S. S., Chakraborty, P., Biswas, J., & Bhattacharya, S. (2014) · Biochimie · doi:10.1016/j.biochi.2014.07.010 · Cited by 21
Short-term exposure of 4-hydroxynonenal induces mitochondria-mediated apoptosis in PC12 cells
Siddiqui, M. A., Kumar, V., Kashyap, M., Agarwal, M., Singh, A. K., Jahan, S., Khanna, V., Al-Khedhairy, A. A., Musarrat, J., & Pant, A. B. (2012) · Human & Experimental Toxicology · doi:10.1177/0960327111432500 · Cited by 24
“Activation of P(53) is associated with a rapid increase in its levels and with an increased ability to bind DNA and mediate transcriptional activation of apoptotic signals.(21,41) Induction in the levels of early response gene proteins such as c-Fos, c-Jun, and GAP-43, which are integral components of transcription fa…”
BackgroundHercog, K., Štern, A., Maisanaba, S., Filipič, M., & Žegura, B. (2020) · Toxins · doi:10.3390/toxins12040219 · Cited by 21
“In response to DNA damage, P53 protein is predominantly activated through its phosphorylation by DNA damage responsive kinases and, to a lesser extent, through the up-regulation of gene expression [84].”
BackgroundBentov, I., Narla, G., Schayek, H., Akita, K., Plymate, S. R., LeRoith, D., Friedman, S. L., & Werner, H. (2008) · Endocrinology · doi:10.1210/en.2007-0844 · Cited by 21
Non-Coding RNA Molecules Connect Calorie Restriction and Lifespan
Abraham, K. J., Ostrowski, L., & Mekhail, K. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.08.020 · Cited by 22
Role of a p53 polymorphism in the development of nonfunctional pituitary adenomas
Yagnik, G., Jahangiri, A., Chen, R., Wagner, J. R., & Aghi, M. K. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.017 · Cited by 20
“TP53 is a ubiquitously expressed tumor suppressor known to be downregulated or dysfunctional in several human tumors (Lakin and Jackson, 1999), but remains understudied and poorly understood in the pathogenesis of pituitary adenoma.”
BackgroundReplication Stress Response Modifies Sarcomeric Cardiomyopathy Remodeling
Pal, S., Nixon, B. R., Glennon, M. S., Shridhar, P., Satterfield, S. L., Su, Y. R., & Becker, J. R. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021768 · Cited by 20
“18 Activation of p53 in cells with DNA damage may lead to apoptosis.”
Probing protein ubiquitination in live cells
Qin, W., Steinek, C., Kolobynina, K. G., Forné, I., Imhof, A., Cardoso, M. C., & Leonhardt, H. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac805 · Cited by 23
“Only upon DNA damage p53 levels increase to affect either cell cycle arrest or trigger apoptosis (104).”
BackgroundTP53 in AML and MDS: The new (old) kid on the block
Marks, J. A., Wang, X., Fenu, E. M., Bagg, A., & Lai, C. (2023) · Blood Reviews · doi:10.1016/j.blre.2023.101055 · Cited by 20
Sestrin2 as a Protective Shield against Cardiovascular Disease
Zahid, M., Abdelsalam, S. S., Raïq, H., Parray, A., Korashy, H. M., Zeidan, A., Elrayess, M. A., & Agouni, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054880 · Cited by 23
“Nutlin-3, a chemical that destabilizes the interaction between p53 and MDM2 increased SESN2 levels and baseline expression of ZFP36L2 to rescue the heart from hypertrophic changes [79].”
BackgroundInfluentialPereira, M. P., Herrity, E., & Kim, D. D. H. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05462-5 · Cited by 22
“[10] TP53 regulates the cell cycle, aids in DNA repair, promotes apoptosis, and prevents tumor formation [11, 12].”
Jovanović, K., Tanić, M., Ivanović, I., Gligorijević, N., Dojčinović, B., & Radulovic, S. S. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.04.011 · Cited by 20
Fukushi, S., Yoshino, H., Yoshizawa, A., & Kashiwakura, I. (2016) · BMC Cancer · doi:10.1186/s12885-016-2585-6 · Cited by 20
“apoptosis, after exposure to various stresses including DNA damage [5].”
BackgroundBaek, J.-H., Lee, J. S., Yun, H. S., Lee, C., Song, J. Y., Um, H., Park, J. K., Park, I., Kim, J., Kim, E. H., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0549-2 · Cited by 21
ZNF185 is a p53 target gene following DNA damage
Smirnov, A., Cappello, A., Lena, A. M., Anemona, L., Mauriello, A., Daniele, N. D., Annicchiarico‐Petruzzelli, M., Melino, G., & Candi, E. (2018) · Aging · doi:10.18632/aging.101639 · Cited by 25
“For instance, Nutlin-3a, an MDM2 antagonist that acts as p53 activator, decreases the expression of integrin alpha5 in colorectal cancer and glioma cells [21,22]; also the expression of integrin beta3 decreases upon DNA-damage in wild-type p53 expressing cells [23]. p53 also regulates focal adhesion and Rho signalling…”
BackgroundInfluentialp53 Signaling on Microenvironment and Its Contribution to Tissue Chemoresistance
Souza, L. C. D. M. E., Faletti, A., Veríssimo, C. P., Stelling, M. P., & Borges, H. L. (2022) · Membranes · doi:10.3390/membranes12020202 · Cited by 21
“Different stress inputs activate different pathways; for example, DNA damage repair mediated by p53 is initiated by Ataxia Telangiectasia Mutant (ATM) activation following double-strand breaks [58]; meanwhile, the cellular response to hypoxia is coordinated by hypoxia-inducible factor 1 (HIF-1) signaling, which also r…”
BackgroundSengupta, S., Ghufran, S. M., Khan, A. A., Biswas, S., & Roychoudhury, S. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02831-4 · Cited by 21
“Moreover, acetylation of p53 by p300 also stimulates DNA-binding activity and transcriptional functions [127, 133, 134, 135].”
BackgroundCao, P., McHugh, M. M., Melendy, T., & Beerman, T. A. (2003) · PubMed · Cited by 24
A retention factor keeps death at bay
Nothwehr, S. F., & Martinou, J. (2003) · Nature Cell Biology · doi:10.1038/ncb0403-281 · Cited by 22
Lebedeva, S., Bagdasarova, S., Tyler, T., Mu, X. Y., Wilson, D. R., & Gjerset, R. A. (2001) · Human Gene Therapy · doi:10.1089/104303401750148685 · Cited by 22
“, 1997), consistent with the established role of p53 as a key mediator of apoptosis in response to stress and DNA damage (Eastman and Rigas, 1999; Lakin and Jackson, 1999; May and May, 1999).”
Valentin, J. (2005) · Annals of the ICRP · doi:10.1016/j.icrp.2005.11.005 · Cited by 20
TP53/p53 Facilitates Stress-Induced Exosome and Protein Secretion by Adipocytes
Huang, Y., Hertzel, A. V., Fish, S. R., Halley, C. L., Bohm, E. K., Martínez, H., Durfee, C. C., Sanders, M. A., Harris, R. S., Niedernhofer, L. J., et al. (2023) · Diabetes · doi:10.2337/db22-1027 · Cited by 19
Genotoxic Mechanisms of PAH‐Induced Immunotoxicity
Gao, J., & Burchiel, S. W. (2014) · Wiley eBooks · doi:10.1002/9783527676965.ch12 · Cited by 20
Pal, I., Dey, K. K., Chaurasia, M., Parida, S., Das, S., Rajesh, Y., Sharma, K., Chowdhury, T., & Mandal, M. (2015) · Tumor Biology · doi:10.1007/s13277-015-4399-6 · Cited by 20
“[87]; this DNA damage-induced apoptosis is caused through”
BackgroundPrasad, R. R., Mishra, D. K., Kumar, M., & Yadava, P. K. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08673 · Cited by 19
“Activation of p53 occurs in response to DNA damage, which further stimulates the transcription of cyclin-dependent kinase (Cdk) inhibitory protein p21 and cell cycle arrest [47].”
BackgroundEl-Khatib, M., Geara, F. B., Haddadin, M. J., & Gali‐Muhtasib, H. U. (2010) · Radiation Oncology · doi:10.1186/1748-717x-5-107 · Cited by 19
“The tumor suppressor protein p53 has been also found to be activated in response to cellular stress, chemotherapeutic drugs and hypoxia [15].”
BackgroundBeneke, R., & Möröy, T. (2001) · Oncogene · doi:10.1038/sj.onc.1205056 · Cited by 21
“The p53 protein induces apoptosis in response to DNA damage but also activates a damage induced cell cycle checkpoint leading to a G1 arrest (for review see: Lakin and Jackson, 1999; Oren, 1999; Deppert, 1994; Enoch and Norbury, 1995; Levine, 1997).”
BackgroundAntioxidant Supplementation: A Linchpin in Radiation-Induced Enteritis
Anwar, M., Ahmad, S., Akhtar, R., Mahmood, A., & Mahmood, S. (2017) · Technology in Cancer Research & Treatment · doi:10.1177/1533034617707598 · Cited by 20
“In the undamaged cells, p53 is bound to Mdm2 and is targeted for ubiquitination and subsequent degradation.(64) However, in the damaged cells, p53 is activated by phosphorylation under the action of upstream kinases.”
BackgroundTargeting apoptosis in clear cell renal cell carcinoma
Kowalewski, A., Borowczak, J., Maniewski, M., Gostomczyk, K., Grzanka, D., & Szylberg, Ł. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116805 · Cited by 19
Indo, H. P., Tomiyoshi, T., Suenaga, S., Tomita, K., Suzuki, H., Masuda, D., Terada, M., Ishioka, N., Gusev, O., Cornette, R., et al. (2015) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-20 · Cited by 20
Rao, C. V., Patlolla, J. M. R., Qian, L., Zhang, Y., Brewer, M. F., Mohammed, A., Desai, D. H., Amin, S., Lightfoot, S. A., & Kopelovich, L. (2013) · Neoplasia · doi:10.1593/neo.131256 · Cited by 19
RUNX3 and p53: How Two Tumor Suppressors Cooperate Against Oncogenic Ras?
Lee, J.-W., van Wijnen, A. J., & Bae, S. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_20 · Cited by 21
Metadata
- Authors
- Lakin, N. D., & Jackson, S. P.
- Affiliations
- University of Cambridge (GB)
- ORCID
- Jackson, Stephen P
- Venue
- Oncogene
- Published
- 1999-12-13
- Volume
- 18
- Issue
- 53
- Pages
- 7644-7655
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2007935491
- Cited by
- 987
- References
- 128
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 30 · 2023: 54 · 2022: 57 · 2021: 46 · 2020: 46 · 2019: 33 · 2018: 40 · 2017: 43 · 2016: 34 · 2015: 33 · 2014: 28 · 2013: 23 · 2012: 28
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, DNA damage response, p53 activation, post-translational modification, phosphorylation, dephosphorylation, acetylation, ionizing radiation, ultraviolet radiation, methyl methanesulfonate, cell cycle arrest, apoptosis, DNA repair, transcriptional activation, hypoxia
- MeSH terms
- Adenosine Triphosphatases, Animals, DNA Damage, DNA Helicases, DNA-Binding Proteins, Humans, Nuclear Proteins, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Signal Transduction, Trans-Activators, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, Saccharomyces cerevisiae Proteins, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.